The result is a new AI-designed cancer treatment plan that avoids standard cancer drugs and relies on drugs that will not ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

Scientists have discovered clues that may explain why some treatments stop working for people with bowel cancer—causing about ...

The number of older women living with a history of breast cancer in the U.S. is growing, which is due to new diagnoses in ...

A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world ...

The International Agency for Research on Cancer forecasts over 35 million new cancer cases in 2050 globally. The growing ...

While less than 1% of cancer patients refuse conventional therapy, some choose alternative care, which can have dire ...

England's National Health Service said Friday it is the first health system in the world to offer a targeted blood cancer ...

French researchers have developed phospholipid degraders that trigger iron-catalyzed cell death in aggressive cancers like ...

NHS England has confirmed that it will be the first health system worldwide to roll out the treatment. The drug will be ...